XML 58 R38.htm IDEA: XBRL DOCUMENT v3.25.4
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Compensation  
Schedule of restricted and performance-based share activity

RSUs

PSUs

Weighted

Weighted

Average

Average

Number of

Grant Date

Number of

Grant Date

Shares

Fair Value

Shares

Fair Value

Unvested as of December 31, 2024

2,250,602

$

17.36

59,137

$

22.06

Granted

1,185,900

$

28.42

437,925

$

28.06

Vested

(771,693)

$

16.30

-

$

-

Forfeited

(590,714)

$

20.84

(81,755)

$

27.51

Unvested RSUs as of December 31, 2025

2,074,095

$

23.09

415,307

$

27.25

Schedule of share option activity under the Plans

Weighted

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Average

  ​ ​ ​

Weighted

Remaining

Average

Contractual

Aggregate

Number of

Exercise

Term

Intrinsic

Shares

Price

(in years)

Value

Outstanding as of December 31, 2024

 

11,286,994

$

15.25

6.49

$

62,334

Granted

 

2,063,891

$

28.58

Exercised

 

(3,202,808)

$

12.37

Forfeited

 

(727,869)

$

22.31

Outstanding as of December 31, 2025

 

9,420,208

$

18.61

6.48

$

213,292

Share options exercisable as of December 31, 2025

 

6,164,885

$

15.86

5.33

$

156,516

Share options vested and expected to vest as of December 31, 2025

 

9,420,208

$

18.61

6.48

$

213,292

Weighted

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Average

  ​ ​ ​

Weighted

Remaining

Average

Contractual

Aggregate

Number of

Exercise

Term

Intrinsic

Shares

Price

(in years)

Value

Outstanding as of December 31, 2024

 

$

$

Granted

 

394,815

$

28.48

Forfeited

 

(95,109)

$

28.41

Outstanding as of December 31, 2025

 

299,706

$

28.50

9.37

$

3,820

Schedule of stock option valuation assumptions presented on weighted-average basis

Years Ended

December 31, 

  ​ ​ ​

2025

2024

  ​ ​ ​

2023

Risk-free interest rate

3.07

%  

4.07

%  

3.96

%  

Expected term (in years)

4.92

6.16

6.15

Expected volatility

50.09

%  

68.29

%  

71.33

%  

Expected dividend yield

%  

%  

%  

Schedule of share-based compensation expense was classified in the consolidated statements of operations and comprehensive income (loss)

Years Ended

December 31, 

  ​ ​ ​

2025

2024

  ​ ​ ​

2023

Cost of goods sold

$

2,125

$

1,623

$

1,812

Research and development expenses

6,646

6,133

5,496

Selling, general and administrative expenses

 

28,232

 

22,937

 

19,841

Share-based compensation expense included in total operating expenses

$

37,003

$

30,693

$

27,149